Quarterly report pursuant to Section 13 or 15(d)

Equity

v3.21.2
Equity
6 Months Ended
Jun. 30, 2020
Stockholders' Equity Note [Abstract]  
Equity

9. EQUITY

 

Preferred stock

 

The holders of Series A Preferred Stock are entitled to receive cumulative dividends at a rate of 9% per annum. The Preferred Stock will automatically convert into common stock when the Company’s common stock market price equals or exceeds $0.28 per share for 30 consecutive days. At conversion, the value of each dollar of preferred stock (based on a $10 per share price) will convert into 7.1429 common shares (which results in a $0.14 per common share conversion rate).

 

In accordance with the terms of the Preferred Stock, cumulative dividends of $89,350 were declared for the six months ended June 30, 2020.

 

Common stock

 

As of year ended December 31, 2019, the Company closed private placements for $0.08 per unit for a total of 1,875,000 units and gross proceeds of $150,000 (the “2019 Units”). Each 2019 Unit was comprised of one common share and two warrants entitling the holder to exercise such warrant for one common share for a period of two years from the date of issuance. The warrants have exercise price of $0.10 per share. See additional description of the detail transactions concerning those warrants in Note 10: Related Party Transactions, below.

 

On August 8, 2019, director Joel Martin Oppenheim exercised warrants to purchase 150,000 shares of common stock for cash proceeds of $15,000 at an exercise price of $0.10 per share. The shares were issued in January 2020.

 

On August 14, 2019, director Joel Martin Oppenheim exercised warrants to purchase 10,000 shares of common stock for cash proceeds of $1,000 at an exercise price of $0.10 per share. The shares were issued in January 2020.

 

On July 23, 2019, Joel Oppenheim, a related party, purchased 1 unit of the debt private placement with gross proceeds of $12,500. At maturity, the holder has the option to either collect the principal or convert the balance into shares/warrants. The conversion would be for 156,250 shares of common stock and warrants to purchase 312,500 shares of common stock at a price of $0.08 per unit. The warrants fair value was determined to be $15,517 via the Black Sholes Option Pricing Model. Consideration for the purchase was provided though a cash payment of $2,500 as well as the forgiving of an outstanding bridge loan of $10,000. The shares were issued in January 2020.

 

On January 20, 2020, a related party, purchased 1 unit of the debt private placement with gross proceeds of $12,500. At maturity, the holder has the option to either collect the principal or convert the balance into shares/warrants. The conversion would be for 156,250 shares of common stock and warrants to purchase 312,500 shares of common stock at a price of $0.08 per unit. Jovian converted the debt into shares during 2020.

 

On February 29, 2020, the Company signed a consulting agreement with a third party to provide Management services related to the SUDS field. The compensation related terms included the issuance of 250,000 shares of Common Stock. The shares were not issued and earned until December 15, 2020.

 

Warrants

 

On September 24, 2015, the Board of Directors of the Company approved the adoption of the 2015 Stock Incentive Plan (the “Plan”). The Plan provides an opportunity, subject to approval of our Board of Directors, of individual grants and awards, for any employee, officer, director or consultant of the Company. The maximum aggregate number of shares of common stock which may be issued pursuant to awards under the Plan, as amended on November 7, 2017, was 40,000,000 shares. The plan was ratified by the stockholders of the Company on April 14, 2016.

 

Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows:

 

    Warrants    

Weighted Average

Exercise Price

 
Outstanding at January 1, 2019     51,066,864     $ 0.20  
Granted     12,250,000       0.15  
Exercised     (125,000 )     0.09  
Expired     (6,148,028 )     0.25  
Outstanding at December 31, 2019     57,043,836     $ 0.14  
Granted     10,400,000       0.16  
Exercised     (1,650,000 )     0.08  
Expired     (17,715,000 )     0.23  
Outstanding at June 30, 2020     48,078,837     $ 0.16  

 

As of June 30, 2020, the weighted-average remaining contractual life of warrants outstanding was 1.10 years (December 31, 2019 – 1.04 years).

 

As of June 30, 2020, the intrinsic value of warrants outstanding is $0.0 (December 31, 2019 - $8,256).

 

The table below summarizes warrant issuances during the six months ended June 30, 2020 and year ended December 31, 2019:

 

    June 30, 2020     December 31, 2019  
Warrants granted:                
Board of Directors and Advisory Board service     3,500,000       7,000,000  
Private placements           3,750,000  
Pursuant to financing arrangements     6,400,000       1,500,000  
Pursuant to consulting agreements     500,000        
Total     10,400,000       12,250,000  

 

The warrants were valued using the Black Scholes Option Pricing Model with the range of assumptions outlined below. Expected life was determined based on historical data of the Company.

 

    June 30, 2020     December 31, 2019  
Risk-free interest rate     1.40% to 1.59 %     1.94% to 2.39 %
Expected life     2.0 -3.5 years       1.0 - 3.0 years  
Expected dividend rate     0 %     0 %
Expected volatility     224% - 226 %     240% - 283 %